The medication entered category M in August, a month after it came off patent for the treatment of neuropathic pain. Pregabalin prices in the drug...
The headlines were alarming: "'Indestructible' headlice now resistant to over-the-counter remedies, researchers warn", said the Daily Telegraph last...
Pfizer’s general patent for Lyrica – of which pregabalin is the active ingredient – expired in 2014, but Pfizer retained the product’s patent for the...
The NHS is no stranger to tightening its belt. Now there is yet another call to ‘trim the fat’ by curtailing the prescribing of drugs that are "of...
The association's director general Warwick Smith said the Health Service Medical Supplies (Costs) Bill – which received royal assent last month (...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter